Vyome Holdings, Inc. (HIND) In the News https://ir.vyometx.com/news-events/in-the-news/rss en-us https://d1io3yog0oux5.cloudfront.net/_d024ecc7eca47b6f52a71f1586e4b046/vyometx/files/theme/images/logo-sm.png Vyome Holdings, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Vyome appoints Jerry Leonard as Chief Financial Officer]]> https://uk.investing.com/news/stock-market-news/vyome-appoints-jerry-leonard-as-chief-financial-officer-93CH-4867682 Mon, 14 Sep 26 00:00:00 -0400 https://uk.investing.com/news/stock-market-news/vyome-appoints-jerry-leonard-as-chief-financial-officer-93CH-4867682 <![CDATA[Vyome receives Chinese patent for acne treatment formulation]]> https://uk.investing.com/news/stock-market-news/vyome-receives-chinese-patent-for-acne-treatment-formulation-93CH-4752801 Wed, 01 Jul 26 00:00:00 -0400 https://uk.investing.com/news/stock-market-news/vyome-receives-chinese-patent-for-acne-treatment-formulation-93CH-4752801 <![CDATA[Vyome Advances VT-1953 Toward Pivotal Stage with FDA Filings and $5.3M Capital Raise]]> https://briefglance.com/companies/vyome-holdings-inc-vyome-therapeutics/pulses/30650 Thu, 28 May 26 00:00:00 -0400 https://briefglance.com/companies/vyome-holdings-inc-vyome-therapeutics/pulses/30650 <![CDATA[Tata group’s Impetis out-licenses arthritis and autoimmune drugs to Vyome]]> https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/tata-groups-impetis-out-licenses-arthritis-and-autoimmune-drugs-to-vyome/articleshow/131076664.cms Thu, 14 May 26 00:00:00 -0400 https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/tata-groups-impetis-out-licenses-arthritis-and-autoimmune-drugs-to-vyome/articleshow/131076664.cms <![CDATA[Tata-backed Impetis licenses JAK inhibitor assets to Vyome Holdings]]> https://www.business-standard.com/companies/news/tata-backed-impetis-licenses-jak-inhibitor-assets-to-vyome-holdings-126051300791_1.html Wed, 13 May 26 00:00:00 -0400 https://www.business-standard.com/companies/news/tata-backed-impetis-licenses-jak-inhibitor-assets-to-vyome-holdings-126051300791_1.html <![CDATA[Vyome Secures Exclusive License for JAK Inhibitors, Targeting $57B Market]]> https://briefglance.com/companies/vyome-holdings-inc-vyome-therapeutics/pulses/29621 Tue, 12 May 26 00:00:00 -0400 https://briefglance.com/companies/vyome-holdings-inc-vyome-therapeutics/pulses/29621 <![CDATA[The next big opportunity lies in immune and rare disease white spaces]]> https://www.indianpharmapost.com/interviews/lite/the-next-big-opportunity-lies-in-immune-and-rare-disease-white-spaces-venkat-nelabhotla-president-ceo-vyome-holdings-44 Tue, 28 Apr 26 00:00:00 -0400 https://www.indianpharmapost.com/interviews/lite/the-next-big-opportunity-lies-in-immune-and-rare-disease-white-spaces-venkat-nelabhotla-president-ceo-vyome-holdings-44 <![CDATA[Vyome Holdings Q4 2025 Earnings Call Highlights]]> https://finance.yahoo.com/sectors/healthcare/articles/vyome-holdings-inc-hind-q4-230038113.html Mon, 30 Mar 26 00:00:00 -0400 https://finance.yahoo.com/sectors/healthcare/articles/vyome-holdings-inc-hind-q4-230038113.html <![CDATA[Vyome Posts Strong Phase 2 Data for VT-1953, Eyes $1B Market Opportunity]]> https://briefglance.com/companies/vyome-holdings-inc-vyome-therapeutics/pulses/29629 Thu, 26 Mar 26 00:00:00 -0400 https://briefglance.com/companies/vyome-holdings-inc-vyome-therapeutics/pulses/29629 <![CDATA[Targeted incentives for innovation-driven research would further strengthen India’s biotech ecosystem]]> https://www.expresspharma.in/targeted-incentives-for-innovation-driven-research-would-further-strengthen-indias-biotech-ecosystem/ Tue, 10 Mar 26 00:00:00 -0400 https://www.expresspharma.in/targeted-incentives-for-innovation-driven-research-would-further-strengthen-indias-biotech-ecosystem/